chlorzoxazone has been researched along with Alloxan Diabetes in 3 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, HW | 1 |
| Bae, SK | 2 |
| Lee, MG | 2 |
| Sohn, YT | 1 |
| Ahn, CY | 1 |
| Jung, YS | 1 |
| Lee, I | 1 |
| Kim, YC | 1 |
| Shin, WG | 1 |
| Li, L | 1 |
| Zhang, Y | 1 |
3 other studies available for chlorzoxazone and Alloxan Diabetes
| Article | Year |
|---|---|
Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
Topics: Animals; Biotransformation; Blood Proteins; Chlorzoxazone; Chromatography, High Pressure Liquid; Cyt | 2006 |
Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
Topics: Administration, Oral; Animals; Area Under Curve; Blood Proteins; Chlorzoxazone; Chromatography, High | 2008 |
[Changes of CYP2E1 activity in diabetic rat model].
Topics: Aniline Hydroxylase; Animals; Chlorzoxazone; Cytochrome P-450 CYP2E1; Diabetes Mellitus, Experimenta | 1998 |